𝛼SK or Searchbullish
Assessing SGX-Listed Healthcare Companies’ Financial & ESG Performance
118 Views24 Jun 2026 14:22
Phidelis Capital's inaugural Phidelis360 report assesses five SGX-listed mid-cap healthcare companies Tianjin Pharma, Haw Par Corp, Raffles...
What is covered in the Full Insight:
- Introduction to Healthcare Companies
- Assessment Criteria
- Financial Performance Analysis
- ESG Performance Review
- Valuation and Investor Considerations
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 51-minute read)
Discussions
(Paid Plans Only)
- Assessing SGX-Listed Healthcare Companies’ Financial & ESG Performance24 Jun 2026
x